Dear patients, colleagues and partners!
I am glad to welcome you on the website of Rostov Research Institute of Oncology! Today our Institute is the largest cancer center in the South of Russia with excellent equipment and highly professional medical staff. Our clinic provides diagnostics and treatment in all spheres of oncology; besides, the Institute has a powerful scientific, experimental and educational base.
Medicine is developing rapidly, and we try to study and implement the best in the fight against cancer. Our main task is to make world-class medical care available for each patient regardless his or her social status, income, place of residence, nationality and religion. We believe that everyone can be helped. Every day we try to move at least one step forward in the diagnostics, treatment and our research, to improve patient care in the clinic. We have achieved a lot, but there is still something to strive for.
Director’s Blog is where I share my thoughts on medicine, on innovations in the Institute, new approaches to cancer treatment and our studies and advice on cancer prevention. My priority as a doctor is your and your loved ones’ health.
Our colleague Prof. Liubov Vladimirova, the Head of Tumor Medical Therapy Department, has just returned from San Francisco. She attended the 2020 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium held January 23-25.
This year, our researchers conducted a large molecular genetic study of pancreatic neuroendocrine tumors (PNETs). PNETs have been studied at the Institute since 2013, and significant results have been achieved in the diagnosis and treatment of this disease.
The Annual Meeting of American Society of Clinical Oncology (ASCO2019), the planet’s largest conference on cancer research and treatment, opens tomorrow in the USA.
Pictured with me are our foreign colleagues from Azerbaijan, Belgium and Germany. They all attended the Russian-Azerbaijan scientific and practical conference on antimicrobial therapy and clinical microbiology on May 15-16, 2019.
April 26, 2019, was a very important day for Rostov Research Institute of Oncology as it was marked by the visit of Veronika Skvortsova, the Minister of Health of Russia.
Dear colleagues and friends!
Best wishes to you on this wonderful holiday, Russian Science Day! Without innovative ideas, discoveries and knowledge, without talented researchers and their enthusiasm, there would be no progress.
A very pleasant meeting. On January 25, Georgy Frank, the chief non-staff specialist in pathological anatomy of the Ministry of Health of Russia, Ph.D. (Doctor of Medical Sciences), Professor, Academician of the Russian Academy of Sciences, came to us, in Rostov Research Institute of Oncology.
The first days of the New Year are marked with two special dates. January 1, 2019, Rostov Research Institute of Oncology celebrated its 88th anniversary. Regional X-ray Radiological Research Institute of Oncology was founded in Rostov-on-Don in 1931.
Dear colleagues and friends! I cordially wish you a Happy New Year! Summing up the results of the outgoing year, I can say that 2018 was a stable and productive year for our Institute.
Rostov Research Institute of Oncology had many changes this year, but this one is the most important for me as a practicing oncologist.
A new accreditation and simulation center for oncology, the first in the South of Russia, was solemnly opened this week in Rostov Research Institute of Oncology.
Valery Savchenko, Ph.D. (Doctor of Medical Sciences), Professor, Academician of the Russian Academy of Sciences, visited Rostov Research Institute of Oncology on November 23. Valery Grigorievich is the General Director of National Medical Research Center for Hematology and the chief non-staff hematologist of the Ministry of Health of Russia.
On November 16, 2018, Rostov Research Institute of Oncology was visited by Igor Viktorovich Korobko, the Director of Department of Science, Innovation Development and Management of Biomedical Health Risks of the Ministry of Health of the Russian Federation.